X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (497) 497
Publication (78) 78
Book Chapter (7) 7
Book Review (4) 4
Conference Proceeding (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pi3-kinase (385) 385
animals (241) 241
humans (196) 196
phosphatidylinositol 3-kinases - metabolism (185) 185
index medicus (161) 161
phosphatidylinositol 3-kinases - antagonists & inhibitors (138) 138
biochemistry & molecular biology (117) 117
mice (114) 114
cell biology (111) 111
phosphorylation (107) 107
oncology (103) 103
signal transduction (99) 99
phosphatidylinositol 3-kinase (97) 97
enzyme inhibitors - pharmacology (88) 88
akt (87) 87
apoptosis (84) 84
activation (82) 82
rats (78) 78
signal transduction - drug effects (71) 71
cells, cultured (66) 66
cell line, tumor (65) 65
morpholines - pharmacology (65) 65
chromones - pharmacology (61) 61
expression (61) 61
cancer (60) 60
androstadienes - pharmacology (56) 56
proto-oncogene proteins c-akt - metabolism (56) 56
male (50) 50
article (48) 48
female (47) 47
cell line (45) 45
pharmacology & pharmacy (45) 45
proto-oncogene proteins c-akt (45) 45
wortmannin (45) 45
phosphoinositide 3-kinase (44) 44
kinase (43) 43
signal transduction - physiology (42) 42
biophysics (39) 39
enzyme activation (39) 39
proto-oncogene proteins - metabolism (39) 39
protein kinase inhibitors - pharmacology (37) 37
apoptosis - drug effects (36) 36
neurosciences (36) 36
pathway (36) 36
phosphatidylinositol 3-kinases - physiology (35) 35
insulin (34) 34
research (34) 34
blotting, western (33) 33
cells (33) 33
inhibition (32) 32
survival (32) 32
chemistry, medicinal (31) 31
growth (31) 31
kinases (31) 31
mtor (31) 31
dose-response relationship, drug (30) 30
protein (30) 30
proliferation (29) 29
protein-kinase (29) 29
proteins (29) 29
insulin - pharmacology (28) 28
pi3‐kinase (28) 28
transfection (28) 28
gene-expression (27) 27
phosphorylation - drug effects (27) 27
protein-serine-threonine kinases - metabolism (26) 26
receptor (26) 26
cell survival - drug effects (25) 25
physiological aspects (25) 25
protein-serine-threonine kinases (25) 25
enzyme activation - drug effects (24) 24
map kinase (24) 24
mitogen-activated protein kinases - metabolism (24) 24
cell proliferation (23) 23
immunology (23) 23
in-vitro (22) 22
rats, wistar (22) 22
signal-transduction (22) 22
tumor cells, cultured (22) 22
antineoplastic agents - pharmacology (21) 21
biological evaluation (21) 21
hematology (21) 21
mutation (21) 21
pi3-kinase/akt (21) 21
analysis (20) 20
angiogenesis (20) 20
cell cycle (20) 20
cell proliferation - drug effects (20) 20
in-vivo (20) 20
nf-kappa-b (20) 20
nitric-oxide synthase (20) 20
p13-kinase (20) 20
phosphatidylinositol 3-kinases - genetics (20) 20
pi3-kinase p110-alpha inhibitors (20) 20
protein kinases (20) 20
pyrimidines - pharmacology (20) 20
pi3k (19) 19
pyridines - pharmacology (19) 19
signaling pathway (19) 19
health aspects (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Liver International, ISSN 1478-3223, 05/2013, Volume 33, Issue 5, pp. 780 - 793
Journal Article
Journal Article
Journal Article
Current Topics in Medicinal Chemistry, ISSN 1568-0266, 12/2016, Volume 16, Issue 30, pp. 3590 - 3616
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 01/2017, Volume 60, Issue 2, pp. 627 - 640
Journal Article
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2016, Volume 59, Issue 3, pp. 985 - 1002
Journal Article
Biology of Reproduction, ISSN 0006-3363, 11/2017, Volume 97, Issue 5, pp. 671 - 687
Journal Article
Journal Article
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2009, Volume 8, Issue 7, pp. 1725 - 1738
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 138, Issue 1, pp. 165 - 173
Abstract Objectives Endometrial carcinoma (EC) is the most common gynecological cancer in the Western World. Treatment options are limited for advanced and... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | NVP-BEZ235 | Endometrioid endometrial cancer | Targeted therapy | AZD6244 | Primary cell culture | MUTATED COLORECTAL-CANCER | ADVANCED SOLID TUMORS | SELUMETINIB AZD6244 | I PI3K INHIBITOR | PHASE-II | ANTITUMOR-ACTIVITY | OBSTETRICS & GYNECOLOGY | DOSE-ESCALATION | UVEAL MELANOMA | ONCOLOGY | PI3-KINASE INHIBITOR | BUPARLISIB BKM120 | TOR Serine-Threonine Kinases - metabolism | raf Kinases - antagonists & inhibitors | Humans | Imidazoles - administration & dosage | ras Proteins - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Quinolines - administration & dosage | raf Kinases - metabolism | Quinolines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Benzimidazoles - administration & dosage | Female | Tumor Cells, Cultured | MAP Kinase Kinase Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - metabolism | Endometrial Neoplasms - enzymology | Carcinoma, Endometrioid - enzymology | ras Proteins - antagonists & inhibitors | Imidazoles - pharmacology | Carcinoma, Endometrioid - drug therapy | Drug Synergism | Xenograft Model Antitumor Assays | Animals | MAP Kinase Signaling System - drug effects | Benzimidazoles - pharmacology | Endometrial Neoplasms - drug therapy | Mice | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Carcinoma | Cancer
Journal Article